36 life science listings in Sweden in 2017: ”They have the next Novo Nordisk”
BY KEVIN GRØNNEMANN
In 2017, 36 pharmaceutical, biotech, and medtech companies went public on the Swedish stock market. Only two firms were listed in Denmark. Industry professionals predict that consequently, Sweden will house the future pharma giants while Denmark misses out on growth and jobs.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.